Compare stocks

Financière de Tubize SA is a Belgian holding company established in 1928, serving as the reference shareholder of UCB, a global biopharmaceutical company. Its sole investment is a significant stake in UCB, focusing on long-term value creation through active participation in UCB's strategic decisions. Headquartered in Brussels, Belgium, the company embodies strong family and entrepreneurial values, uniting descendants of UCB's founder, Emmanuel Janssen, and like-minded investors. This strategic positioning provides UCB with the stability necessary for sustained growth and investment in new products for patients with serious illnesses.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.